Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

124.04
Delayed Data
As of Aug 28
 +1.00 / +0.81%
Today’s Change
83.16
Today|||52-Week Range
140.72
+10.89%
Year-to-Date

Today’s Trading

Previous close123.04
Today’s open122.38
Day’s range121.87 - 124.44
Volume4,598,423
Average volume (3 months)4,797,641
Market cap$98.1B
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+41.84%
Earnings growth (this year)+29.37%
Earnings growth (next 5 years)+24.13%
Revenue growth (last year)+17.89%
P/E ratio47.0
Price/Sales12.24
Price/Book15.21

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.04+0.10%
BMYBristol-Myers Squibb-0.21-0.35%
LLYEli Lilly and Co-0.55-0.66%
ABBVAbbVie-0.53-0.82%
Data as of 4:04pm ET, 08/28/2015

Financials

Next reporting dateOctober 22, 2015
EPS forecast (this quarter)$1.21
Annual revenue (last year)$7.6B
Annual profit (last year)$2.0B
Net profit margin26.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts

Partner Offers